Banyan Partners’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Banyan Partners's TEVA Position: Q3 2014 in Review
Banyan Partners reduced its Teva Pharmaceutical Industries (TEVA) stake by 55% in Q3 2014, selling an estimated $1.83M and leaving 28,323 shares worth $1.52M. The position accounts for 0.13% of the portfolio, ranked #181.
Banyan Partners first reported a position in TEVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.71M in Q1 2014. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.
- Banyan Partners held 28,323 shares of Teva Pharmaceutical Industries worth $1.52M as of Q3 2014.
- Banyan Partners sold 34,488 Teva Pharmaceutical Industries shares in Q3 2014, an estimated $1.83M.
- Teva Pharmaceutical Industries made up 0.13% of Banyan Partners's portfolio in Q3 2014, its #181 holding.
- Banyan Partners first reported a position in Teva Pharmaceutical Industries in Q2 2013 and has held it in 6 quarters since.
- Banyan Partners's Teva Pharmaceutical Industries position peaked at $3.71M in Q1 2014.
- 773 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2014.
Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.